BACKGROUND: Individuals with schizophrenia use psychoactive substances more frequently than the general population. The genetic vulnerability to develop schizophrenia may also increase risk for the development of substance use disorders. We examine this hypothesis by assessing the rates of substance use disorders and nicotine use in non-psychotic siblings of individuals with schizophrenia. METHODS: Participants included 59 individuals with DSM-IV schizophrenia, 53 of their siblings, 80 community controls, and 75 of their siblings. Statistical regression was used to assess the rates of substance use disorders and nicotine use in study participants while controlling for age, gender, lifetime diagnosis of a mood or anxiety disorder, and a family history of substance use disorder. RESULTS: Individuals with schizophrenia and their non-psychotic siblings reported higher rates of alcohol and cannabis use disorders and nicotine use when compared to siblings of comparison subjects. CONCLUSIONS: The vulnerability to develop schizophrenia may also extend to substance use disorders. Future research is needed to investigate the neurobiological basis of increased substance use in non-psychotic siblings and the psychosocial mechanisms that may contribute to increased substance use in non-psychotic siblings.
BACKGROUND: Individuals with schizophrenia use psychoactive substances more frequently than the general population. The genetic vulnerability to develop schizophrenia may also increase risk for the development of substance use disorders. We examine this hypothesis by assessing the rates of substance use disorders and nicotine use in non-psychotic siblings of individuals with schizophrenia. METHODS:Participants included 59 individuals with DSM-IV schizophrenia, 53 of their siblings, 80 community controls, and 75 of their siblings. Statistical regression was used to assess the rates of substance use disorders and nicotine use in study participants while controlling for age, gender, lifetime diagnosis of a mood or anxiety disorder, and a family history of substance use disorder. RESULTS: Individuals with schizophrenia and their non-psychotic siblings reported higher rates of alcohol and cannabis use disorders and nicotine use when compared to siblings of comparison subjects. CONCLUSIONS: The vulnerability to develop schizophrenia may also extend to substance use disorders. Future research is needed to investigate the neurobiological basis of increased substance use in non-psychotic siblings and the psychosocial mechanisms that may contribute to increased substance use in non-psychotic siblings.
Authors: Michael J Lyons; Jessica L Bar; William S Kremen; Rosemary Toomey; Seth A Eisen; Jack Goldberg; Stephen V Faraone; Ming Tsuang Journal: J Abnorm Psychol Date: 2002-11
Authors: F Scott Hall; Andre Der-Avakian; Thomas J Gould; Athina Markou; Mohammed Shoaib; Jared W Young Journal: Neurosci Biobehav Rev Date: 2015-06-06 Impact factor: 8.989
Authors: Matthew J Smith; Lei Wang; Will Cronenwett; Morris B Goldman; Daniel Mamah; Deanna M Barch; John G Csernansky Journal: Schizophr Res Date: 2011-06-12 Impact factor: 4.939
Authors: Meghana S Karnik-Henry; Lei Wang; Deanna M Barch; Michael P Harms; Carolina Campanella; John G Csernansky Journal: Schizophr Res Date: 2012-04-26 Impact factor: 4.939
Authors: Jibran Y Khokhar; Lucas L Dwiel; Angela M Henricks; Wilder T Doucette; Alan I Green Journal: Schizophr Res Date: 2017-04-14 Impact factor: 4.939
Authors: Matthew J Smith; Derin J Cobia; James L Reilly; Jodi M Gilman; Andrea G Roberts; Kathryn I Alpert; Lei Wang; Hans C Breiter; John G Csernansky Journal: Hippocampus Date: 2015-03-11 Impact factor: 3.899
Authors: Matthew J Smith; Derin J Cobia; Lei Wang; Kathryn I Alpert; Will J Cronenwett; Morris B Goldman; Daniel Mamah; Deanna M Barch; Hans C Breiter; John G Csernansky Journal: Schizophr Bull Date: 2013-12-15 Impact factor: 9.306